{"url_path":"/sec/exoz/8-k/2026-06-26/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/2010788/0001493152-26-030205-index.html","accession_number":"0001493152-26-030205","cik":"0002010788","ticker":"EXOZ","issuer_name":"EXOZYMES INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2010788/0001493152-26-030205-index.html","primary_entity_key":"0002010788","primary_entity_name":"EXOZYMES INC."},"word_count":79,"has_tables":true,"body_markdown":"**Item 9.01.**\n**Financial Statements\nand Exhibits.**\n\n \n\n**(d)\nExhibits**\n\n \n\nExhibits\n \nDescription\nof Exhibit\n\n \n \n \n\n99.1*\n \n[Press Release, dated June 24, 2026](ex99-1.htm)\n\n \n \n \n\n104*\n \nCover Page Interactive\nData File (embedded within the Inline XBRL Document).\n\n \n\n*\nFiled herewith\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDate:\nJune 25, 2026\nEXOZYMES INC.\n\n \n \n \n\n \nBy\n*/s/\nFouad Nawaz*\n\n \n \nFouad\nNawaz,\n\n \n \nVice\nPresident, Finance"}